ROBERTO MARTICORENA MARTINEZ: Open Payments
NPI 1952764466 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,221 in 83 payments from 13 companies in 2025. Trend: 2023 $2,452 · 2024 $1,884 · 2025 $2,221
Food & beverage: $2,221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $500 |
| E.R. Squibb & Sons, L.L.C. | 11 | $389 |
| Otsuka America Pharmaceutical, Inc. | 8 | $213 |
| Lundbeck LLC | 8 | $185 |
| Janssen Pharmaceuticals, Inc | 7 | $181 |
| Alkermes, Inc. | 7 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $140 |
| Axsome Therapeutics, Inc. | 5 | $127 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| ABBVIE INC. | 4 | $79 |
Products named: UZEDY, REXULTI, COBENFY, ARISTADA, CAPLYTA, INVEGA SUSTENNA, Auvelity, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
